1 ial infarction, according to progestin type: norethindrone, 2.2 (1.5 to 3.2) and 2.3 (1.3 to 3.9); le

2                                              Norethindrone acetate (NETA), another progestin used in

3 ition, other potent steroid agonists such as norethindrone and mometasone furoate have larger substit

4 stigens, norethynodrel, cyproterone acetate, norethindrone, and megestrol acetate, were found to be o

5 thinyl estradiol at a dose of 35 microg plus norethindrone at a dose of 0.5 to 1 mg for 12 cycles of

6  in the metribolone complex to 520 A3 in the norethindrone complex, 565 A3 in the progesterone comple

7 progestogens (principally levonorgestrel and norethindrone) continues.

8 es induced by 2, 20, and 200 ng/L P4, RU486, norethindrone (NET), and levonorgestrel (LNG).

9 rogestins used in oral contraceptives (e.g., norethindrone, norgestrel, and norethynodrel), hormone r

10 iphasic dosing with an average of 0.75 mg of norethindrone (OR, 3.1; 95% CI, 1.9-5.1; Pheterogeneity